{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T16:59:00Z","timestamp":1783097940406,"version":"3.54.6"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Beijing Demonstration Research Ward Construction Project","award":["2022-YJXBF-04-05"],"award-info":[{"award-number":["2022-YJXBF-04-05"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-024-03963-5","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T16:02:19Z","timestamp":1721059339000},"page":"400-408","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A novel nomogram for predicting the risk of persistent hyperparathyroidism after kidney transplantation"],"prefix":"10.1007","volume":"86","author":[{"given":"Changyu","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congrong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haotian","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenshan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,15]]},"reference":[{"issue":"4","key":"3963_CR1","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2215\/CJN.06040710","volume":"6","author":"J Cunningham","year":"2011","unstructured":"J. Cunningham, F. Locatelli, M. Rodriguez, Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin. J. Am. Soc. Nephrol. 6(4), 913\u2013921 (2011). https:\/\/doi.org\/10.2215\/CJN.06040710","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"5","key":"3963_CR2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s40265-019-01074-4","volume":"79","author":"R Delos Santos","year":"2019","unstructured":"R. Delos Santos, A. Rossi, D. Coyne, T.T. Maw, Management of post-transplant hyperparathyroidism and bone disease. Drugs 79(5), 501\u2013513 (2019). https:\/\/doi.org\/10.1007\/s40265-019-01074-4","journal-title":"Drugs"},{"issue":"2","key":"3963_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/ctr.12291","volume":"28","author":"N Muirhead","year":"2014","unstructured":"N. Muirhead, J.S. Zaltman, J.S. Gill, D.N. Churchill, M. Poulin-Costello, V. Mann et al. Hypercalcemia in renal transplant patients: prevalence and management in Canadian transplant practice. Clin. Transpl. 28(2), 161\u2013165 (2014). https:\/\/doi.org\/10.1111\/ctr.12291","journal-title":"Clin. Transpl."},{"issue":"11","key":"3963_CR4","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s11255-016-1391-z","volume":"48","author":"Celtik A","year":"2016","unstructured":"Celtik A, S. Sen, M. Yilmaz, M.S. Demirci, G. Asci, A.F. Tamer et al. The effect of hypercalcemia on allograft calcification after kidney transplantation. Int Urol. Nephrol. 48(11), 1919\u20131925 (2016). https:\/\/doi.org\/10.1007\/s11255-016-1391-z","journal-title":"Int Urol. Nephrol."},{"issue":"3","key":"3963_CR5","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1097\/SLA.0000000000004069","volume":"273","author":"S Dream","year":"2021","unstructured":"S. Dream, H. Chen, B. Lindeman, Tertiary hyperparathyroidism: Why the delay? Ann. Surg. 273(3), e120\u2013e122 (2021). https:\/\/doi.org\/10.1097\/SLA.0000000000004069","journal-title":"Ann. Surg."},{"issue":"4","key":"3963_CR6","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/SLA.0000000000001431","volume":"262","author":"I Lou","year":"2015","unstructured":"I. Lou, D. Foley, S.K. Odorico, G. Leverson, D.F. Schneider, R. Sippel et al. How well does renal transplantation cure hyperparathyroidism? Ann. Surg. 262(4), 653\u2013659 (2015). https:\/\/doi.org\/10.1097\/SLA.0000000000001431","journal-title":"Ann. Surg."},{"issue":"1","key":"3963_CR7","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/TP.0000000000000823","volume":"100","author":"M Wolf","year":"2016","unstructured":"M. Wolf, M.R. Weir, N. Kopyt, R.B. Mannon, J. Von Visger, H. Deng et al. A prospective cohort study of mineral metabolism after kidney transplantation. Transplantation 100(1), 184\u2013193 (2016). https:\/\/doi.org\/10.1097\/TP.0000000000000823","journal-title":"Transplantation"},{"issue":"12","key":"3963_CR8","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/j.ekir.2020.09.010","volume":"5","author":"Y Itano","year":"2020","unstructured":"Y. Itano, S. Kato, M. Tsuboi, H. Kasuga, Y. Tsuruta, F. Sato et al. A prospective, randomized clinical trial of etelcalcetide in patients receiving hemodialysis with secondary hyperparathyroidism (the DUET Trial). Kidney Int Rep. 5(12), 2168\u20132177 (2020). https:\/\/doi.org\/10.1016\/j.ekir.2020.09.010","journal-title":"Kidney Int Rep."},{"issue":"1","key":"3963_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.surg.2021.03.067","volume":"171","author":"W Sutton","year":"2022","unstructured":"W. Sutton, X. Chen, P. Patel, S. Karzai, J.D. Prescott, D.L. Segev et al. Prevalence and risk factors for tertiary hyperparathyroidism in kidney transplant recipients. Surgery 171(1), 69\u201376 (2022). https:\/\/doi.org\/10.1016\/j.surg.2021.03.067","journal-title":"Surgery"},{"key":"3963_CR10","doi-asserted-by":"publisher","unstructured":"M. Miedziaszczyk, K. Lacka, O. Tomczak, A. Bajon, M. Primke, I. Idasiak-Piechocka. Systematic review of the treatment of persistent hyperparathyroidism following kidney transplantation. Biomedicines. 2022;11(1). https:\/\/doi.org\/10.3390\/biomedicines11010025.","DOI":"10.3390\/biomedicines11010025"},{"issue":"5","key":"3963_CR11","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.suc.2009.06.011","volume":"89","author":"SC Pitt","year":"2009","unstructured":"S.C. Pitt, R.S. Sippel, H. Chen, Secondary and tertiary hyperparathyroidism, state of the art surgical management. Surg. Clin. North Am. 89(5), 1227\u20131239 (2009). https:\/\/doi.org\/10.1016\/j.suc.2009.06.011","journal-title":"Surg. Clin. North Am."},{"issue":"1","key":"3963_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","volume":"7","author":"Kidney Disease: Improving Global Outcomes CKDMBDUWG","year":"2017","unstructured":"Kidney Disease: Improving Global Outcomes CKDMBDUWG, KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int. Suppl. (2011) 7(1), 1\u201359 (2017). https:\/\/doi.org\/10.1016\/j.kisu.2017.04.001","journal-title":"Kidney Int. Suppl. (2011)"},{"issue":"6","key":"3963_CR13","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.kint.2018.12.024","volume":"95","author":"P Evenepoel","year":"2019","unstructured":"P. Evenepoel, K. Claes, B. Meijers, M.R. Laurent, B. Bammens, M. Naesens et al. Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients. Kidney Int 95(6), 1461\u20131470 (2019). https:\/\/doi.org\/10.1016\/j.kint.2018.12.024","journal-title":"Kidney Int"},{"issue":"2","key":"3963_CR14","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1097\/JS9.0000000000000894","volume":"110","author":"BC Kim","year":"2024","unstructured":"B.C. Kim, H. Kim, C.H. Baek, Y.H. Kim, S.J. Pak, D. Kwon et al. Predictive factors for persistent hypercalcemia following parathyroidectomy in patients with persistent hyperparathyroidism after kidney transplantation: a retrospective cohort study. Int. J. Surg. 110(2), 902\u2013908 (2024). https:\/\/doi.org\/10.1097\/JS9.0000000000000894","journal-title":"Int. J. Surg."},{"issue":"11","key":"3963_CR15","doi-asserted-by":"publisher","first-page":"e14085","DOI":"10.1111\/ctr.14085","volume":"34","author":"O Isakov","year":"2020","unstructured":"O. Isakov, R. Ghinea, P. Beckerman, E. Mor, L.V. Riella, T. Hod, Early persistent hyperparathyroidism post-renal transplantation as a predictor of worse graft function and mortality after transplantation. Clin. Transpl. 34(11), e14085 (2020). https:\/\/doi.org\/10.1111\/ctr.14085","journal-title":"Clin. Transpl."},{"issue":"7","key":"3963_CR16","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.2215\/CJN.15921221","volume":"17","author":"N Hong","year":"2022","unstructured":"N. Hong, J. Lee, H.W. Kim, J.J. Jeong, K.H. Huh, Y. Rhee, Machine learning-derived integer-based score and prediction of tertiary hyperparathyroidism among kidney transplant recipients: An integer-based score to predict tertiary hyperparathyroidism. Clin. J. Am. Soc. Nephrol. 17(7), 1026\u20131035 (2022). https:\/\/doi.org\/10.2215\/CJN.15921221","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"5","key":"3963_CR17","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1093\/ndt\/gfh128","volume":"19","author":"P Evenepoel","year":"2004","unstructured":"P. Evenepoel, K. Claes, D. Kuypers, B. Maes, B. Bammens, Y. Vanrenterghem, Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Nephrol. Dial. Transpl. 19(5), 1281\u20131287 (2004). https:\/\/doi.org\/10.1093\/ndt\/gfh128","journal-title":"Nephrol. Dial. Transpl."},{"issue":"8","key":"3963_CR18","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1681\/ASN.2015060622","volume":"27","author":"JM Cruzado","year":"2016","unstructured":"J.M. Cruzado, P. Moreno, J.V. Torregrosa, O. Taco, R. Mast, C. Gomez-Vaquero et al. A randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism. J. Am. Soc. Nephrol. 27(8), 2487\u20132494 (2016). https:\/\/doi.org\/10.1681\/ASN.2015060622","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"3963_CR19","doi-asserted-by":"publisher","first-page":"426","DOI":"10.5582\/bst.2022.01320","volume":"16","author":"B Wang","year":"2022","unstructured":"B. Wang, W. Li, Q. Wang, W. Zhang, Timing of parathyroidectomy for kidney transplant patients with secondary hyperparathyroidism: A practical overview. Biosci. Trends 16(6), 426\u2013433 (2022). https:\/\/doi.org\/10.5582\/bst.2022.01320","journal-title":"Biosci. Trends"},{"issue":"2","key":"3963_CR20","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/TP.0000000000000583","volume":"99","author":"H Pihlstrom","year":"2015","unstructured":"H. Pihlstrom, D.O. Dahle, G. Mjoen, S. Pilz, W. Marz, S. Abedini et al. Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism. Transplantation 99(2), 351\u2013359 (2015). https:\/\/doi.org\/10.1097\/TP.0000000000000583","journal-title":"Transplantation"},{"issue":"5","key":"3963_CR21","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.surg.2017.12.010","volume":"163","author":"M Araujo","year":"2018","unstructured":"M. Araujo, J.A.M. Ramalho, R.M. Elias, V. Jorgetti, W. Nahas, M. Custodio et al. Persistent hyperparathyroidism as a risk factor for long-term graft failure: the need to discuss indication for parathyroidectomy. Surgery 163(5), 1144\u20131150 (2018). https:\/\/doi.org\/10.1016\/j.surg.2017.12.010","journal-title":"Surgery"},{"issue":"10","key":"3963_CR22","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1111\/ajt.12425","volume":"13","author":"P Perrin","year":"2013","unstructured":"P. Perrin, S. Caillard, R.M. Javier, L. Braun, F. Heibel, C. Borni-Duval et al. Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation. Am. J. Transpl. 13(10), 2653\u20132663 (2013). https:\/\/doi.org\/10.1111\/ajt.12425","journal-title":"Am. J. Transpl."},{"issue":"6","key":"3963_CR23","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.2215\/CJN.01310308","volume":"3","author":"P Evenepoel","year":"2008","unstructured":"P. Evenepoel, B.K. Meijers, H. de Jonge, M. Naesens, B. Bammens, K. Claes et al. Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation. Clin. J. Am. Soc. Nephrol. 3(6), 1829\u20131836 (2008). https:\/\/doi.org\/10.2215\/CJN.01310308","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"4","key":"3963_CR24","first-page":"295","volume":"54","author":"GM Chertow","year":"2000","unstructured":"G.M. Chertow, M. Plone, M.A. Dillon, S.K. Burke, E. Slatopolsky, Hyperparathyroidism and dialysis vintage. Clin. Nephrol. 54(4), 295\u2013300 (2000)","journal-title":"Clin. Nephrol."},{"issue":"1","key":"3963_CR25","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2215\/CJN.12941213","volume":"10","author":"F Tentori","year":"2015","unstructured":"F. Tentori, M. Wang, B.A. Bieber, A. Karaboyas, Y. Li, S.H. Jacobson et al. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clin. J. Am. Soc. Nephrol. 10(1), 98\u2013109 (2015). https:\/\/doi.org\/10.2215\/CJN.12941213","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"4","key":"3963_CR26","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/jcsm.12722","volume":"12","author":"H Komaba","year":"2021","unstructured":"H. Komaba, J. Zhao, S. Yamamoto, T. Nomura, D.S. Fuller, K.P. McCullough et al. Secondary hyperparathyroidism, weight loss, and longer term mortality in haemodialysis patients: results from the DOPPS. J. Cachexia Sarcopenia Muscle 12(4), 855\u2013865 (2021). https:\/\/doi.org\/10.1002\/jcsm.12722","journal-title":"J. Cachexia Sarcopenia Muscle"},{"issue":"23","key":"3963_CR27","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1001\/jama.288.23.3014","volume":"288","author":"AM Ball","year":"2002","unstructured":"A.M. Ball, D.L. Gillen, D. Sherrard, N.S. Weiss, S.S. Emerson, S.L. Seliger et al. Risk of hip fracture among dialysis and renal transplant recipients. JAMA 288(23), 3014\u20133018 (2002). https:\/\/doi.org\/10.1001\/jama.288.23.3014","journal-title":"JAMA"},{"issue":"3","key":"3963_CR28","doi-asserted-by":"publisher","first-page":"685","DOI":"10.2215\/CJN.03930808","volume":"4","author":"S Mazzaferro","year":"2009","unstructured":"S. Mazzaferro, M. Pasquali, F. Taggi, M. Baldinelli, C. Conte, M.L. Muci et al. Progression of coronary artery calcification in renal transplantation and the role of secondary hyperparathyroidism and inflammation. Clin. J. Am. Soc. Nephrol. 4(3), 685\u2013690 (2009). https:\/\/doi.org\/10.2215\/CJN.03930808","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"3","key":"3963_CR29","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1525-139X.2006.00161.x","volume":"19","author":"E Lewin","year":"2006","unstructured":"E. Lewin, J. Huan, K. Olgaard, Parathyroid growth and suppression in renal failure. Semin Dial. 19(3), 238\u2013245 (2006). https:\/\/doi.org\/10.1111\/j.1525-139X.2006.00161.x","journal-title":"Semin Dial."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03963-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-03963-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-03963-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T05:39:28Z","timestamp":1727761168000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-03963-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,15]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["3963"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-03963-5","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,15]]},"assertion":[{"value":"2 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Clinical Research Ethics Committee of China-Japan Friendship Hospital (approval number: 2023-KY-122).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}